Search

everythinglearnresearchcommunity

for

Search:↓

Frontal fibrosing alopecia is a scarring hair loss condition mainly affecting older women, with no known cause and treatments that may help stabilize hair loss.

The symposium concluded that hair growth involves complex processes, including the hair follicle life cycle, the role of the dermal papilla, hair strength, pigmentation, and the impact of diseases and treatments like minoxidil on hair and skin.

Finasteride and minoxidil are effective for hair regrowth, while treatments for alopecia areata have varying success and continuous treatment is necessary.

Oral dutasteride and topical pimecrolimus can safely and effectively treat Frontal Fibrosing Alopecia, leading to significant hair regrowth.

The document concludes that alopecia areata is an autoimmune disease without a definitive cure, but treatments like corticosteroids are commonly used.

The cause of Frontal Fibrosing Alopecia is unclear, diagnosis involves clinical evaluation and various treatments exist, but their effectiveness is uncertain.

HIV can cause unusual and severe skin problems that are hard to treat.

Scarring alopecias are complex hair loss disorders that require early treatment to prevent permanent hair loss.

Hormonal changes after childbirth and menopause can lead to women's hair loss and facial hair growth, with a need for better treatments.

Thyroid diseases may contribute to autoimmune skin diseases, and more research is needed on their relationship.

Minoxidil promotes hair regrowth, but more research needed for effectiveness and response factors.

Alopecia Areata is an autoimmune hair loss condition that needs more research for better treatments.

Dermatologists are crucial for managing skin side effects in metastatic melanoma patients using vemurafenib and ipilimumab.

A certain medication improved severe itching in a boy with liver and bowel disease by reducing histamine levels, suggesting a new treatment target.

Higher CRBP1 levels are linked to more severe alopecia areata.

Blocking IL-17 can reduce skin inflammation in a mouse model of pityriasis rubra pilaris.

No link between scalp patterns and alopecia severity in children, but more severe cases often had nail abnormalities.

Stress can cause a type of hair loss in mice lacking the CCHCR1 gene.

PDE inhibitors, especially PDE4 inhibitors like apremilast, are effective for certain inflammatory skin conditions but have side effects and can be costly.

Chronic kidney disease can cause hair loss, which may be related to zinc deficiency or certain medications, and sometimes hair grows back when the underlying issue is treated.

Manipulating the catagen and telogen phases of hair growth could lead to treatments for hair disorders.

Some patients developed skin inflammation after obesity surgery, and a medication called dapsone helped treat it.

Psoriasis can cause temporary or permanent hair loss.

A 5-year-old boy's skin condition improved with systemic valganciclovir after a cardiac transplant and immunosuppressive therapy.

Syphilis has a wide range of symptoms that can look like other diseases, and if not treated, it can progress to a more serious stage, especially in HIV-positive patients.

Early diagnosis and aggressive treatment are key for managing rare scalp disorders that cause permanent hair loss.

New treatments for hair loss show promise, but more development is needed, especially for tough cases.

Injecting platelet-rich plasma or applying it with a laser or microneedling can treat hair loss effectively. The laser and microneedling methods cause less pain.

Hormone imbalances from endocrine diseases can cause various skin conditions that help diagnose and treat these diseases early.

Topical treatment is recommended for Folliculitis decalvans in pregnant women.